Table 1 Comparing between the mean of daily doses of antidiabetic agents in well-controlled diabetes patients and that of non-controlled diabetes patients
From: Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?
Medicines | Well-controlled T2D | Non-controlled T2D | P value |
|---|---|---|---|
Metformin (g/day) | 1.81 ± 0.43 (50) | 1.92 ± 0.23 (21) | 0.70 |
Glibenclamide (mg/day) | 55.00 ± 6.51 (05) | 7.00 ± 2.12 (02) | 0.18 |
Glimepiride (mg/day) | 3.00 ± 0.97 (22) | 2.30 ± 0.48 (10) | 0.00* |
Insulin (IU/day) | 25.50 ± 11.70 (04) | 43.00 ± 4.24 (02) | 0.12 |